Family Medicine Doctors in San Carlos, AZ Accepting Medicare
7 Family Medicine doctors found. Showing 1 - 7
 Dr. Douglas E Brinkerhoff, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 223 Cibecue Circle Rd, San Carlos, AZ 85550 Phone: 928-475-7219 |
Peter Wesley Eaton, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 223 Cibecue Circle Rd, San Carlos, AZ 85550 Phone: 928-475-7219 |
 Theresa A. Covello, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 223 Cibeque Circle Road, San Carlos, AZ 85550 Phone: 928-475-7219 Fax: 928-475-7370 |
Wen-te Ted Chen, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 223 Cibecue Circle Rd, San Carlos, AZ 85550 Phone: 928-475-7219 |
Dr. Carlos Duarte, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Vassar Dr Ne, Usphs Indian Hospital, San Carlos, AZ 85550 Phone: 928-475-7190 |
Karen Sue Heath, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 223 Cibeque Circle Road, San Carlos, AZ 85550 Phone: 928-475-7219 Fax: 928-475-7370 |
Luis Angel Rodriguez, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 223 Cibecue Circle, San Carlos Phs Indian Hospital, San Carlos, AZ 85550 Phone: 928-475-7219 Fax: 928-475-7370 |
News Archive
Diflunisal drug reduces neurological decline in patients with familial transthyretin amyloidosis
A recent study led by researchers from the Amyloidosis Center at Boston University School of Medicine and Boston Medical Center demonstrates that diflunisal, a generic anti-inflammatory drug, successfully reduced neurological decline and preserved the quality of life in patients with familial transthyretin amyloidosis. Diflunisal is an inexpensive and safe medication marketed over the past 40 years for arthritis and pain.
A novel strategy to uncover new antibiotics
Resistance to antibiotics has been steadily rising, posing a threat to public health. Now, a method from Mohammad Seyedsayamdost, an assistant professor of chemistry at Princeton University, may open the door to the discovery of a host of potential drug candidates.
Data from Phase 3 clinical trials of PROVENGE in advanced prostate cancer to be presented at ASCO 2010
Dendreon Corporation today announced the upcoming presentation of data from integrated analyses of three Phase 3 PROVENGE (sipuleucel-T) clinical trials of an autologous cellular immunotherapy in advanced prostate cancer, to be presented at the annual meeting of the American Society of Clinical Oncology in Chicago on Monday, June 7 at 8:00 a.m. CT.
FDA-approved drug eliminates immune cells that destroys hair follicles in people with alopecia areata
Researchers at Columbia University Medical Center (CUMC) have identified the immune cells responsible for destroying hair follicles in people with alopecia areata, a common autoimmune disease that causes hair loss, and have tested an FDA-approved drug that eliminated these immune cells and restored hair growth in a small number of patients.
› Verified 1 days ago
Family Medicine
Internal Medicine
Emergency Medicine
Pediatrics